Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.79 USD | +0.71% | +0.71% | -29.19% |
01/05 | MDxHealth SA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
01/05 | Transcript : MDxHealth SA, Q1 2024 Earnings Call, May 01, 2024 |
Business Summary
Number of employees: 300
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Clinical Laboratory Service Testing
99.7
%
| 37 | 99.8 % | 70 | 99.7 % | +89.27% |
Royalties and Other
0.3
%
| 0 | 0.2 % | 0 | 0.3 % | +256.25% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
99.3
%
| 37 | 99.2 % | 70 | 99.3 % | +89.59% |
Europe
0.7
%
| 0 | 0.7 % | 0 | 0.7 % | +71.84% |
Rest of the World
0.0
%
| 0 | 0.0 % | 0 | 0.0 % | 0.00% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 18/19/18 | |
Ron Kalfus
DFI | Director of Finance/CFO | 50 | 22/19/22 |
Miriam Reyes
COO | Chief Operating Officer | - | - |
Joseph Sollee
CMP | Compliance Officer | 60 | 10/03/10 |
Harry Rentrop
PRN | Corporate Officer/Principal | - | - |
John Bellano
PRN | Corporate Officer/Principal | 56 | 19/19/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Donnie Hardison
BRD | Director/Board Member | 74 | 29/21/29 |
Eric Bednarski
BRD | Director/Board Member | 52 | 30/20/30 |
Hilde Windels
BRD | Director/Board Member | 59 | 01/17/01 |
Chief Executive Officer | 62 | 18/19/18 | |
Koen Hoffman
CHM | Chairman | 56 | 01/18/01 |
Director/Board Member | 58 | 01/20/01 | |
Lieve Verplancke
BRD | Director/Board Member | 65 | 26/17/26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 27,288,093 | 25,630,246 ( 93.92 %) | 0 | 93.92 % |
Company contact information
MDxHealth SA
CAP Business Center Zone Industrielle des Hauts-Sarts
4040, Herstal
+32 4 257 70 21
http://www.mdxhealth.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.19% | 75.59M | |
+46.62% | 58.71B | |
-3.36% | 41.31B | |
+36.42% | 39.2B | |
-10.22% | 27.4B | |
+10.15% | 26.55B | |
-22.26% | 18.98B | |
+1.09% | 12.51B | |
+26.35% | 12.08B | |
+20.81% | 11.94B |
- Stock Market
- Equities
- MDXH Stock
- Company MDxHealth SA